Group One Trading’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,410
| Closed | -$28K | – | 8895 |
|
|
2022
Q1 | $28K | Buy |
3,410
+2,515
| +281% | +$25.7K | ﹤0.01% | 6534 |
|
|
2021
Q4 | $12K | Sell |
895
-5,885
| -87% | -$148K | ﹤0.01% | 7296 |
|
|
2021
Q3 | $296K | Sell |
6,780
-3,725
| -35% | -$161K | ﹤0.01% | 4765 |
|
|
2021
Q2 | $439K | Buy |
10,505
+5,685
| +118% | +$250K | ﹤0.01% | 4358 |
|
|
2021
Q1 | $233K | Buy |
4,820
+1,810
| +60% | +$105K | ﹤0.01% | 4873 |
|
|
2020
Q4 | $296K | Buy |
3,010
+2,680
| +812% | +$235K | ﹤0.01% | 3745 |
|
|
2020
Q3 | $23K | Sell |
330
-110
| -25% | -$9.6K | ﹤0.01% | 5071 |
|
|
2020
Q2 | $46K | Buy |
+440
| New | +$52.3K | ﹤0.01% | 4423 |
|
|
2019
Q1 | – | Sell |
-200
| Closed | -$16K | – | 5573 |
|
|
2018
Q4 | $16K | Sell |
200
-350
| -64% | -$34.5K | ﹤0.01% | 4122 |
|
|
2018
Q3 | $58K | Sell |
550
-2,765
| -83% | -$263K | ﹤0.01% | 3888 |
|
|
2018
Q2 | $332K | Buy |
3,315
+3,240
| +4,320% | +$367K | ﹤0.01% | 2642 |
|
|
2018
Q1 | $9K | Buy |
75
+5
| +7% | +$780 | ﹤0.01% | 4360 |
|
|
2017
Q4 | $12K | Sell |
70
-105
| -60% | -$26.9K | ﹤0.01% | 4337 |
|
|
2017
Q3 | $55K | Sell |
175
-660
| -79% | -$208K | ﹤0.01% | 3590 |
|
|
2017
Q2 | $248K | Sell |
835
-680
| -45% | -$182K | ﹤0.01% | 2485 |
|
|
2017
Q1 | $350K | Buy |
+1,515
| New | +$262K | ﹤0.01% | 2127 |
|
|
2016
Q3 | – | Sell |
-10
| Closed | -$1K | – | 5041 |
|
|
2016
Q2 | $1K | Sell |
10
-20
| -67% | -$2K | ﹤0.01% | 4538 |
|
|
2016
Q1 | $3K | Sell |
30
-40
| -57% | -$4.53K | ﹤0.01% | 4329 |
|
|
2015
Q4 | $11K | Sell |
70
-255
| -78% | -$38.2K | ﹤0.01% | 4153 |
|
|
2015
Q3 | $35K | Buy |
+325
| New | +$42.1K | ﹤0.01% | 3751 |
|
Other funds holding CALA
Group One Trading's CALA Position: Q1 2023 in Review
Group One Trading sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 660 shares — an estimated $2.15K sold.
Group One Trading first reported a position in CALA in Q4 2015 and held it in 17 quarters. The position peaked at $673K in Q4 2020. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- Group One Trading reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 660 Calithera Biosciences, Inc shares in Q1 2023, an estimated $2.15K.
- Group One Trading first reported a position in Calithera Biosciences, Inc in Q4 2015 and held it in 17 quarters.
- Group One Trading's Calithera Biosciences, Inc position peaked at $673K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.